Pharmaceuticals & Biotech
All industriesIndustry report · generated from Pharmaceuticals & Biotech's indicators
Pharmaceuticals & Biotech, full AI read
Pharmaceuticals & Biotech (Healthcare) ranks #12/50 on the Industry Transformation Index (80.1). Its standout dimension is Growth outlook (85.0, Strong). AI tends to automate 34%, augment 52% and leave 14% human.
Sector
Healthcare
US employment
0.9M
Gross value added
$525bn
Work split
34% automate · 52% augment · 14% human
Dimension read
| Dimension | Value | Standing | What a high vs low value means, and where Pharmaceuticals & Biotech sits |
|---|---|---|---|
| ITI Transformation (ITI) | 80.1 | Strong · #12/50 | High here, AI is reshaping this sector fast, major disruption and opportunity. ▲ high: AI is reshaping this sector fast, major disruption and opportunity · ▼ low: AI is reshaping it slowly, more stable, less near-term upheaval |
| AI exposure AI exposure | 85.0 | Strong · #12/50 | High here, most of its work is exposed to current AI. ▲ high: most of its work is exposed to current AI · ▼ low: its work is largely outside current AI's reach |
| AI adoption AI adoption | 78.0 | Moderate · #18/50 | Mid-pack. High would mean AI is already widely used across the sector; low would mean AI is barely adopted yet, laggard or untapped headroom. ▲ high: AI is already widely used across the sector · ▼ low: AI is barely adopted yet, laggard or untapped headroom |
| Productivity uplift Productivity uplift | 72.0 | Strong · #12/50 | High here, large near-term AI productivity gains are available. ▲ high: large near-term AI productivity gains are available · ▼ low: limited AI productivity upside |
| Growth outlook Growth outlook | 85.0 | Strong · #10/50 | High here, strong growth outlook in an AI economy. ▲ high: strong growth outlook in an AI economy · ▼ low: weak growth outlook |
Strengths
- Growth outlook (85.0, Strong), strong growth outlook in an AI economy.
- Transformation (ITI) (80.1, Strong), AI is reshaping this sector fast, major disruption and opportunity.
- AI exposure (85.0, Strong), most of its work is exposed to current AI.
Risk factors
- Balanced AI profile with no acute structural gap.
▲
These are model outputs and scenarios, not forecasts of actual outcomes. This platform measures access to, utilization of, and leverage from cognitive infrastructure, not intelligence. No causality or certainty is claimed.